Citi Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $140
With 84% Ownership, Cardinal Health, Inc. (NYSE:CAH) Boasts of Strong Institutional Backing
Citigroup Adjusts Price Target on Cardinal Health to $140 From $130, Maintains Neutral Rating
Cardinal Health (CAH) Receives a Hold From Citi
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note
Morgan Stanley Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $142
Those Who Invested in Cardinal Health (NYSE:CAH) Five Years Ago Are up 196%
BofA Securities Maintains Cardinal Health(CAH.US) With Buy Rating
Here's Why Cardinal Health (CAH) Is a Strong Value Stock
Cardinal Health Is Maintained at Buy by B of A Securities
Express News | Cardinal Health Inc : BofA Global Research Raises Price Objective to $155 From $150
ESG Still Matters. 3 Defensive Stocks That Make the Grade. -- Barrons.com
Trending Industry Today: Tempus AI Leads Losses In AI Medical Concept Stocks
Returns Are Gaining Momentum At Cardinal Health (NYSE:CAH)
Express News | Telix Pharmaceuticals Limited -Selects Cardinal Health as Distributor for Gozellix in U.S.
Telix Announces Cardinal Health for Gozellix Commercial Distribution
U.S. Stocks Poised for Earnings Surprises in April
Cardinal Health (CAH) Stock Moves -1.14%: What You Should Know
Does Cardinal Health (NYSE:CAH) Deserve A Spot On Your Watchlist?
Leerink Partners Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $161